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Cell Stem Cell
Editors’ NotesFactoring in the Niche
Hematopoiesis, the production of blood cells, is a life-long process that is dependent upon hematopoietic stem cells (HSCs), which
can differentiate into all blood cell lineages. Two research papers in this issue examine some of the external factors influencing HSC
cell-fate decisions. Staal and colleagues consider the role of Wnt, a morphogen known to differentially regulate cell-fate decisions
during development, often via the formation of precise concentration gradients. Here, the authors find that the same idea holds
true for HSCs, with Wnt signaling levels differentially affecting lineage fate determination. Understanding how such external cues
factor into cell-fate decisions will likely be important for therapeutics that require expanding specific lineages. Another external factor
recently shown to influence HSC fate determination is hypoxia. Quiescent HSCs reside in the osteoblastic niche, which is relativelyEnhanced HSC function
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Impaired hematopoiesishypoxic. HIF-1 (hypoxia inducible factor-1) regulates quiescence
of HSCs by altering their metabolism. As reviewed by Suda in this
issue, the specific metabolic balance seen in HSCs is crucial for
their maintenance and function, but the underlying mechanism
between hypoxia and metabolism has been unclear. Karlsson
and colleagues now show that HIF-1 signaling upregulates
expression of the niche-related factor Cripto and its membrane
receptor GRP78 in HSCs, which stimulates expression of glycol-
ysis-related genes. Due to itsmembrane localization, the authors
point out that GRP78 can also be used as a marker to identify
quiescent cells within the heterogeneous HSC population.
Reprogramming Reexamined
The past several months have seen enormous strides in the
conversion of human fibroblasts into induced neuronal (iN) cells.
Questions remained, however, about which cells within the
heterogeneous fibroblast population were giving rise to neurons,
because fibroblast cultures contain cells of varying maturation
stage and origin, and can include neural crest cells. In this issue,
Wernig and colleagues address such issues using homogeneous
populations of terminally differentiated hepatocytes and show
that these cells can be converted into iN cells, providing exciting
evidence that reprogramming is also possible between cellsfrom different germ layers. Alongside the rapid advances being made in the reprogramming field, reports have emerged suggesting
that the reprogramming process itself might introduce serious genetic instability. Because reprogrammed cells could one day be
used therapeutically, there is clear interest in determining whether the process is inherently mutagenic. Here, Hall and colleagues
more closely examine the genomes of three mouse iPSC lines and find, in contrast to previous reports, no evidence of spontaneous
mutations or transpositions. Although some of the discrepancies between this paper and other studies could be due to species differ-
ences, this underscores the potential for—and importance of—identifying nonmutagenic reprogramming protocols. As the genetic
stability of iPSCs is debated, new research is set to reignite discussion
of somatic cell nuclear transfer (SCNT) as a method for reprogramming
human cells. In this issue, a Letter from Egli and colleagues describes
the regulatory hurdles faced over the course of their studies in this area,
and a Forum from Insoo Hyun offers suggestions on how such SCNT
research can move forward ethically.
A Lifetime of Self-Renewal
Although both embryonic and adult tissues contain stem cell popula-
tions, little is known about the mechanistic commonalities regulating
their pluripotency. Recent reports implicated Sox2, a transcription
factor known to affect embryonic pluripotency, in some progenitor
populations in adult tissues as well, but a full-scale adult expression
analysis has been missing. In this issue, Hochedlinger and colleagues
show that adult mice have widespread Sox2 expression (see also the
Preview by Driessens and Blanpain). Using fate mapping analysis,
they also show that many of these adult Sox2+ cells were also Sox2+
embryonically, suggesting that the gene targets of this transcription
factor could be long-term regulators of cellular self-renewal and differentiation (see also the Preview by Etchegaray and Mostoslav-
sky on new findings on the mechanism of Sox2-mediated transcription). It will be fascinating to see whether this widespread expres-
sion of Sox2 is relevant for tumorigenesis or cancer stem cells (CSCs). Characterization of CSC self-renewal properties also moves
forward apace, and in this issue, von Kalle and colleagues show that there is heterogeneity within tumor-initiating cells in human colon
cancer (see also the Preview by Zeuner and DeMaria). Some cells contribute to the formation of primary tumors and can also initiate
new tumors. Others only enhance growth of the primary tumor, while a third population is relatively inactive in the primary tumor, but
can drive the formation of new tumors. Identifying the molecular mechanisms governing these functions could offer new targets for
cancer therapeutics.Cell Stem Cell 9, October 7, 2011 ª2011 Elsevier Inc. xi
